Mediastinoscopy: still the gold standard

Area of Science:

• Pulmonology
• Thoracic Surgery
• Oncology

Background:

• Endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) is an evolving technique for mediastinal lymph node evaluation in non-small cell lung cancer (NSCLC).
• Its diagnostic accuracy compared to traditional mediastinoscopy remains a subject of ongoing debate.

Purpose of the Study:

• To critically evaluate the accuracy and cost-effectiveness of EBUS-TBNA versus mediastinoscopy for NSCLC mediastinal staging.
• To determine if EBUS-TBNA offers a proven benefit over mediastinoscopy for routine staging.

Main Methods:

• Comparative analysis of diagnostic sensitivity and specificity for EBUS-TBNA and mediastinoscopy.
• Review of existing cost-benefit studies, questioning their methodologies and conclusions.

Main Results:

• EBUS-TBNA sensitivity is comparable to mediastinoscopy for enlarged mediastinal lymph nodes.
• Sensitivity is lower for normal-sized lymph nodes, with a higher false-negative rate.
• Existing cost-benefit analyses are flawed and suggest questionable economic advantages for EBUS-TBNA.

Conclusions:

• While EBUS-TBNA has specific advantages in certain clinical scenarios, its routine use for upper mediastinal staging in NSCLC is not yet supported by proven benefits over mediastinoscopy.
• The reliability of non-malignant EBUS-TBNA results requires further investigation due to a higher false-negative rate.